期刊文献+

腹膜恶性间皮瘤7例临床病理分析 被引量:3

Peritoneal malignant mesothelioma:a clinicopathologic analysis of 7 cases
下载PDF
导出
摘要 目的探讨腹膜恶性间皮瘤(PMM)的临床病理特征、免疫表型、鉴别诊断、治疗及预后。方法对7例PMM的临床资料、病理特点及免疫组化标记进行研究,并复习相关文献。结果 PMM好发于中老年人,平均年龄为61.5岁,临床主要表现为腹胀、腹痛、腹水、腹部包块等。镜下肿瘤组织形态多样,由上皮样细胞和梭形细胞2种类型组成,具有向上皮和肉瘤样双向分化的特点。免疫组化示calretinin(6例)、AE1/AE3(7例)、EMA(5例)、CK5/6(5例)、HBME-1(6例)、vimentin(7例)均(+),CEA均(-)。随访6~30个月,2例死亡,5例存活。结论 PMM对其确诊需结合临床特征、病理形态及免疫表型,根据肿瘤细胞异型程度、核分裂象多少和核的多形性,恶性间皮瘤可分为低度恶性和高度恶性。且需与腹腔原发或转移的其他肿瘤相鉴别。 Objective To investigate the clinicopathologic features, immunophenotype, differential diagnosis, therapy and prognosis of peritoneal malignant mesothelioma (PMM). Methods Clinical data, pathological features and immunohistochemical markers were analyzed in seven patients with PMM with review of the related literatures. Results PMM occurred predominantly in middle-aged persons, with a median age of 61.5 years. Major clinical manifestations consisted of abdominal distention, abdominal pain, ascites and abdomen swelling. Microscopically, tumor had morphological diversity, which was composed of epithelioid cell and spindle cell with characteristics of epithelioid or sarcomatoid differentiation. Immunohistochemically, the tumor cells were positive for calretinin(6/7 ), AE1/AE3 (7/7), EMA (5/7), CK5/6 (5/7), HBME-1 (6/7), vimentin (7/7), but negative for CEA of all cases. 2 patients had died, and 5 patients survived by follow-up. Conclusions PMM is a peritoneal primary and rare tumor. Its diagnosis should depend on clinical features, pathological and immunohistochemistry. According to the cellulariry of neoplasm, the number of mitotic figures and nuclear heteromorphism, PMM can be divided into low grade and high grade malignancy. It needs to be distinguished from celiac primary or metastatic malignant tumors.
出处 《诊断病理学杂志》 CSCD 北大核心 2013年第5期267-270,共4页 Chinese Journal of Diagnostic Pathology
关键词 腹膜 恶性间皮瘤 免疫组化 临床病理 Peritoneal Malignant mesothelioma Immunohistochemically Clinical pathology
  • 相关文献

参考文献12

二级参考文献24

  • 1邓明佳,沈丽达.恶性胸膜间皮瘤15例临床分析[J].现代肿瘤医学,2006,14(9):1085-1087. 被引量:1
  • 2Yaziji H,Battifora H,Barry T,黄文斌(摘译).12种抗体对区分上皮样间皮瘤和腺癌的评价:3种抗体具有最大的敏感性和特异性[J].临床与实验病理学杂志,2006,22(5):574-574. 被引量:14
  • 3Miettinen M,Kvatich AJ.HBME-1:a monoclonal antibody useful in the differential diagnosis of mesothelioma,adenocarcinoma and soft-tissue and bone tumors.Appl Immunohistochem,1995,3:115 被引量:1
  • 4Attanoos RL,Goddard H,Gibbs AR.Mesothelioma-binding antibodys:thrombomodulin,OV632 and HBME-1 and their use in the diagnosis of malignant mesothelioma.Histopathology,1996,29:209 被引量:1
  • 5Ordonez NG.Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.Am J Surg Pathol,1998,22:1203 被引量:1
  • 6Takeichi M.Cadherin cell adhesion receprors as a morphogenetic regulator.Science,1991,251:1451 被引量:1
  • 7Han AC,Soler AP,knudsen KA et al. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed,paraffin-embedded tissues.Hum Pathol,1997,28:641 被引量:1
  • 8Souhami RL,Beverley PC,Bobrow LG.Antigens of small cell lung cancer.First International Workshop Lancet,1987,2:325 被引量:1
  • 9Edwards C,Oates J.OV632 and MOC31 in the diagnosis of mesothelioma and adenocarcinoma:an assessment of their use in formalin-fixed and paraffin wax embedded material.J Clin Pathol,1995,48:626 被引量:1
  • 10Ueda G,Sawada M,Ogawa H et al. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the overy.Gynecol Oncol,1993,51:219 被引量:1

共引文献28

同被引文献23

  • 1Swerdlow SH,Campo E,Harris NL,et al.Wold Health Organigation classification of tumors.Pathologic and genetic of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2008.164. 被引量:1
  • 2Swerdlow SH,Campo E,Harris NL,et al.World Health Organization classification.Pathologic and genetic of tumors of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2008.233-237. 被引量:1
  • 3Hans CP,Weisenburger DD,Greiner TC.Confirmation of the molecalar classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue micro array[J].Blood,2004,103 (1):275-282. 被引量:1
  • 4Wang J,Sun NC,Nozawa Y,et al.Histological and immunohistochemieal characterization of extranodal diffuse largecell lymphomas with prominent spindle cell features[J].Histopathology,2001,39 (5):476-481. 被引量:1
  • 5Carbone A,Gloghini A,Libra M,et al.A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin[J].Mod Pathol,2006,19 (2):299-306. 被引量:1
  • 6Tas F,Keskin S,Karadeniz A,et al.Noncutaneous melanoma have distinct feature from each other and cuteneous melanoma[J].Oncology,2011,81(5-6):353-358. 被引量:1
  • 7Cristaudo A, Bonotti A, Simonini S, et al. Soluble markers for di- agnosis of malignant pleural mesoth-elioma [ J ]. Biomark Med, 2011,5(2) :261-273. 被引量:1
  • 8Rai AJ, Flores RM, Mathew A, et al. protein biomarkers for malig- nant mesothehoma: analytical validation of ELISA based assays and characterization at mRNA and protein level [ J ]. Clin Chem Lab Med,2010,48(2) :271-278. 被引量:1
  • 9Luo L, Shi HZ, Liang QL, et al. Diagnostic value of soluble me- sothelin-related peptides for malignant mesothelioma: a meta-anal- vsisr J1. Respir Med,2010,104( 1 ) :149-156. 被引量:1
  • 10I-Iassan R, Bera T, Pastan I. MSLN : a new target for immunothera- py [ J ]. Clin Cancer Res,2004,10 ( 12Ptl ) :3937-3942. 被引量:1

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部